Novo Nordisk drugs
16 results
Alhemo (concizumab)
(concizumab)Novo Nordisk
Usage: Alhemo is indicated for routine prophylaxis to prevent or reduce bleeding episodes in adults and pediatric patients aged 12 and older with hemophilia A (factor VIII deficiency with inhibitors) and hemophilia B (factor IX deficiency with inhibitors).
Fiasp (insulin aspart injection)
(insulin aspart injection)Novo Nordisk
Usage: FIASP is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
Levemir (insulin detemir)
(insulin detemir)Novo Nordisk
Usage: LEVEMIR is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. However, it is not recommended for treating diabetic ketoacidosis.
Macrilen (macimorelin acetate)
(Macimorelin acetate)Novo Nordisk
Usage: MACRILEN is indicated for the diagnosis of adult growth hormone deficiency (AGHD). Its safety and diagnostic effectiveness have not been established for subjects with a body mass index (BMI) over 40 kg/m².
Norditropin (somatropin)
(somatropin)Novo Nordisk
Usage: NORDITROPIN is indicated for treating pediatric growth failure due to growth hormone deficiency, various syndromes, and idiopathic short stature. It is also used in adults for growth hormone deficiency replacement therapy.
Novolog (insulin aspart)
(insulin aspart)Novo Nordisk
Usage: NOVOLOG is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus.
Novolog mix 70/30 (insulin aspart)
(insulin aspart)Novo Nordisk
Usage: NOVOLOG MIX 70/30 is indicated for improving glycemic control in adults with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis and has fixed proportions of rapid-acting and long-acting insulins, limiting dose adjustments for basal and prandial needs.
Ozempic (semaglutide)
(semaglutide)Novo Nordisk
Usage: OZEMPIC is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. It also reduces the risk of major adverse cardiovascular events in patients with cardiovascular disease and lowers the risk of kidney-related complications in those with chronic kidney disease.
Rivfloza (nedosiran)
(nedosiran)Novo Nordisk
Usage: RIVFLOZA is indicated for lowering urinary oxalate levels in children aged 2 years and older and adults with primary hyperoxaluria type 1 (PH1) who have relatively preserved kidney function (eGFR ≥30 mL/min/1.73 m²).
Rybelsus (oral semaglutide)
(Oral Semaglutide)Novo Nordisk
Usage: RYBELSUS is indicated alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not for use in patients with type 1 diabetes mellitus.